Autres langues IRADIMED CORPORATION

Actions

IRMD

US46266A1097

Temps réel estimé Cboe BZX Autres places de cotation 19:31:59 14/05/2024			Varia. 5j.	Varia. 1 janv.
41,85 ^USD	-1,41%		-4,21%	-11,84%

02/05	Transcript : IRADIMED CORPORATION, Q1 2024 Earnings Call, May 02, 2024
02/05	IRADIMED CORPORATION annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Earnings Flash (IRMD) IRADIMED CORPORATION Posts Q1 Revenue $17.6M	02/05
Earnings Flash (IRMD) IRADIMED CORPORATION Reports Q1 EPS $0.36	02/05
IRadimed: Q1 Earnings Snapshot	02/05
IRADIMED CORPORATION Reports Earnings Results for the First Quarter Ended March 31, 2024	02/05
IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share	02/05
IRADIMED CORPORATION Declares Regular Quarterly Cash Dividend, Payable on May 30, 2024	02/05
IRADIMED CORPORATION Provides Revenue Guidance for the Second Quarter of 2024; Reiterates Earnings Guidance for the Full Year of 2024	02/05
IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd	25/04
IRadimed Files $75 Million Common Stock Shelf Registration	03/04
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference	13/03
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference	13/03
IRadimed: Q4 Earnings Snapshot	08/02
Earnings Flash (IRMD) IRADIMED CORPORATION Posts Q4 Revenue $17.5M	08/02
Earnings Flash (IRMD) IRADIMED CORPORATION Reports Q4 EPS $0.39	08/02
IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results	08/02
IRadimed Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	08/02
IRadimed Corporation Provides Revenue Guidance for the First Quarter and Full Year of 2024	08/02
North American Morning Briefing : S&P 500 to Open -2-	08/02
IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.	01/02
IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue	09/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues IRADIMED CORPORATION

Actions

IRMD

US46266A1097

Autres langues

Filtres